Dimensional Fund Advisors
IMMX icon

Dimensional Fund Advisors’s Immix Biopharma IMMX Stock Holding History

Dimensional Fund Advisors’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,528
Closed -$75.3K – 3392
2024
Q1 		$75.3K Buy
24,528
+12,613
+106% +$48.8K ﹤0.01% 3295
2023
Q4 		$82.5K Hold
11,915
– – ﹤0.01% 3295
2023
Q3 		$40.7K Buy
11,915
+4
+0% +$9 ﹤0.01% 3395
2023
Q2 		$32K Buy
+11,911
New +$24.9K ﹤0.01% 3431

Other funds holding IMMX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors's IMMX Position: Q2 2024 in Review

Dimensional Fund Advisors sold out of Immix Biopharma (IMMX) in Q2 2024, closing a stake of 24,528 shares — an estimated $75.3K sold.

Dimensional Fund Advisors first reported a position in IMMX in Q2 2023 and held it in 4 quarters. The position peaked at $82.5K in Q4 2023. 31 funds tracked by Wall St. Rank hold IMMX as of Q2 2024.

  • Dimensional Fund Advisors reported no remaining Immix Biopharma position as of Q2 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 24,528 Immix Biopharma shares in Q2 2024, an estimated $75.3K.
  • Dimensional Fund Advisors first reported a position in Immix Biopharma in Q2 2023 and held it in 4 quarters.
  • Dimensional Fund Advisors's Immix Biopharma position peaked at $82.5K in Q4 2023.
  • 31 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2024.

Based on Dimensional Fund Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.